Global /China /Healthcare /Drug Manufacturers - General /002107
chevron_leftBack
Shandong Wohua Pharmaceutical Co., Ltd. logo

Shandong Wohua Pharmaceutical Co., Ltd.

002107
SHE: 002107 Delayed
7.31CNY -3.1%
1.08 USD
As of 17 June 2026, Shandong Wohua Pharmaceutical Co., Ltd. has a market cap of $644.05M USD, ranking #13523 globally and #4110 in China. It ranks #1220 in the Healthcare sector, and #453 in the Drug Manufacturers - General industry.
Global Rank
13523
Country Rank
4110
Sector Rank
1220
Industry Rank
453
Key Stats
Market Cap
$644.05MUSD
4.35B CNY
Enterprise Value
$587.4MUSD
3.98B CNY
Revenue (TTM)
$121.07MUSD
818.16M CNY
EBITDA (TTM)
$20.2MUSD
136.73M CNY
Net Income (TTM)
$16.2MUSD
109.5M CNY
EBITDA Margin
17%
Profit Margin
13%
PE Ratio
39.4
PS Ratio
5.3
PB Ratio
6.5
EV/EBITDA
28.9
Company Profile
Country (HQ)
Sector
Healthcare
Industry
Drug Manufacturers - General
CEO
Shengting Li open_in_new
Employees
1,018
Founded
2003
Website
wohua.cn open_in_new
warningChart data may be delayed
1d 1w 1m 3m 6m 1y
-3.1% -0.5% 19% 1.2% 21% 59%

News

Loading...

Markets

Exchange Ticker Price
Shenzhen Stock Exchange
MIC: XSHE
PRIMARY
002107
山东沃华医药科技股份有限公司 Class A
ISIN: CNE000001QB8
Shares Out.:
577.21M1 Shares Float: 576.726M2
TV:
SA:
YF:
GF:
BA:
MS:
7.31 CNY
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.

About Shandong Wohua Pharmaceutical Co., Ltd.

Shandong Wohua Pharmaceutical Co., Ltd. manufactures and sells pharmaceutical products in China. The company produces and sells tablets, granules, capsules, oral liquid, and pills; medicinal herb cultivation; and provides pharmaceutical technology consulting services. It also offers products including drugs for cardiovascular, cerebrovascular, and nervous system diseases, such as Wohua Xinkeshu tablets, Hedan tablets and capsules, Naoxueshu and Shenzhiling oral liquid, and Tongluo Huatan capsules; and drugs for musculoskeletal disorders, including Gusukang capsules/granules and Yidu Hanbi liquid; Yidu cold-rheumatism medicinal wine ingredients; brain blood circulation oral solution; Amber stone granules for urinary system diseases; Children's antipyretic granules for pediatric medication; Anti-itching granules for skin diseases; and Bile grass capsule for digestive and gynecological diseases, as well as Silkworm Nourishing Blood and Benefiting Kidney Granules for gynecological medication. In addition, the company offers Amber Xiaoshi granules, and Siyu Yangxue Yishen granules; Yanreqing granules, Antiviral oral liquid, and Niuhuang Yijin tablets for the treatment of dry throat and sore throat; Yinhuang granules for the treatment of wind-heat colds; Tongxuan Lifei pills for the treatment of wind-cold colds; Fangfeng Tongsheng pills for colds on the surface and heat inside; Huoxiang Zhengqi Water for the treatment of summer-heat colds; Shenling Baizhu, Buzhong Yiqi, and Xiangsha Liujun pills for the treatment of physical weakness colds; and Juhong Li Gao for the treatment of dry coughs with little sputum. The company was founded in 2003 and is based in Weifang, China. Shandong Wohua Pharmaceutical Co., Ltd. operates as a subsidiary of Beijing Zhongzheng Wanrong Investment(Group) Co., Ltd.

Similar Companies

Industry: Drug Manufacturers - General (China)
Name
Market Cap diff.
PE
$54.0B
364.89B CNY
8K%
44.9
603259
$49.78B
336.36B CNY
8K%
17.2
$28.53B
223.48B HKD
4K%
35.7
$18.81B
147.32B HKD
3K%
162.3
$16.56B
111.89B CNY
2K%
-
9926
$16.02B
125.46B HKD
2K%
-
Industry: Drug Manufacturers - General (Global)
Name
Market Cap diff.
PE
LLY
$761.68B
118K%
38.1
JNJ
$547.28B
85K%
26.4
ABBV
$360.63B
56K%
97.4
$322.73B
256.25B CHF
50K%
19.9
AZN
$289.3B
215.59B GBP
45K%
27.6
NOVN
$275.68B
218.9B CHF
43K%
20.5
chevron_leftBack